Author
Senior reporter
Covid-19: Big pharma to the rescue
As the world watches and waits for a vaccine, we ask what IR is like under the pandemic spotlight
‘The scrutiny is extraordinarily high,’ says Nick Mazing, director of research at Sentieo, talking about the media and market focus on pharmaceuticals and biotech firms involved in the fight against Covid-19. ‘And it’s not just scrutiny. It is interference.’
As
Content Preview
to continue reading
Subscribe
- IR Essentials - print editions
- Unlimited Articles online
- Newsletter
- Award Winning IR reports
- Strategy guides
- White papers
from$995*
Case studies
The way companies are valued in capital markets appears to be undergoing a fundamental shift. There’s growing consensus that business should focus on...Read more
The latest research from IR Magazine shows a gap in the way that companies and investors focus on different stakeholder issues, with more...Read more
As the last glimpses of summer weather start to fade away, and the sounds of barbecues, sprinklers and soccer chants disappear to be replaced by the...Read more
IR Magazine has released a new report investigating the changing nature of attitudes toward stakeholder issues and the effect this has upon...Read more
